JONESBORO, GA, UNITED STATES, October 14, 2026 /EINPresswire.com/ -- Simply Sheds USA, an American manufacturer of ...

LP Building Solutions (LP), a leading manufacturer of high-performance building products, today announced the expansion of ...

Demand for shake-style accents remains strong across many housing markets, particularly for gables and architectural focal points. The new profile addresses that trend with a smaller reveal that ...

Weyerhaeuser , Louisiana-Pacific and other lumber and building products makers face flat-to-down demand, persistent affordability issues, and fading confidence in a housing market recovery ...

Louisiana-Pacific has an average rating of overweight and mean price target of $93.46, according to analysts polled by FactSet.

On “Run Away” he sings, “there’s nothing left to say/On desolation day,” brightening the grim wanderlust of his lyrics with a sweetly ascending California folk-rock track. “In the Night” is peak Drake ...

Forbes contributors publish independent expert analyses and insights. Robert Glatter is a New York-based physician covering public health. This voice experience is generated by AI. Learn more. This ...

The much-anticipated Lp(a)HORIZON trial testing whether the novel drug pelacarsen can improve cardiovascular outcomes by decreasing lipoprotein(a) levels has failed to meet its primary endpoint.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Please provide your email address to receive an email when new articles are posted on . Pelacarsen did not reduce cardiovascular events in patients with elevated lipoprotein(a) compared with placebo.

The result calls into question other late-stage trials testing Lp(a)-lowering drugs from the likes of Amgen and Eli Lilly. (iStock / Getty Images Plus) Novartis’ Ionis-partnered drug designed to lower ...